SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Safety of blood supply in the Caribbean countries: Role of screening blood donors for markers of hepatitis B and C viruses
13 references·2 citing·32 second hop
Safety of blood supply in the Caribbean countries: Role of screening blood donors for markers of hepatitis B and C viruses (2005)Safety of blood supply in the Caribbean c…Safety of the Blood Supply in Latin America (2005)Safety of the Blood Supply in…Window‐period human immunodeficiency virus transmission to two recipients by an adolescent blood donor (2004)Window‐period human immunodef…Transfusion risks of yesterday and of today (2003)Transfusion risks of yesterda…Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. (2003)Incidence and estimated rates…Human immunodeficiency virus‐1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing (2003)Human immunodeficiency virus‐…Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001 (2003)Estimation of the risk of hep…International application of the Incidence Rate/Window Period model (2002)International application of …Estimated risk of transfusion‐transmitted viral infections in Spain (2002)Estimated risk of transfusion…Screening for viral markers in volunteer and replacement blood donors in West Africa (2001)Screening for viral markers i…Reducing the Risk of Blood Transfusion (2001)Reducing the Risk of Blood Tr…Transfusion‐transmitted infectious diseases in Argentina, 1995 through 1997 (2000)Transfusion‐transmitted infec…Risk for Transfusion-Transmitted Infectious Diseases in Central and South America (1998)Risk for Transfusion-Transmit…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Seroprevalence, cost per donation and reduction in blood supply due to positive and indeterminate results for infectious markers in a blood bank in Lima, Peru (2017)Seroprevalence, cost per dona…Blood donors' attitudes towards voluntary non‐remunerated donation in Trinidad and Tobago (2017)Blood donors' attitudes towar…The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007 (2009)Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study (2010)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Effect of a National Disaster on Blood Supply and Safety (2003)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)The risks of transfusion-transmitted infection: direct estimation and mathematical modelling (2000)Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations (2006)Detection of HIV‐1 infection in blood donors during the immunological window period using the nucleic acid‐amplification technology (2007)Modeling the transmission risk of emerging infectious diseases through blood transfusion (2012)Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. (2001)Tattoos and transfusion-transmitted disease risk: implications for the screening of blood donors in Brazil (2002)ORGANIZACION PANAMERICANA DE LA SALUD (2003)World Development Report 1990. (1990)Current risk for transfusion transmitted infections (2007)Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS‐II study, 2007 to 2008 (2009)The risk of transfusion‐transmitted infections in sub‐Saharan Africa (2009)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Current Safety of the Blood Supply in the United States (2004)HIV Transmission Through Transfusion—Missouri and Colorado, 2008 (2011)Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 2009 (2012)Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Residual risk of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy (2005)Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010 (2012)Reducing replacement donors in Sub‐Saharan Africa: challenges and affordability (2007)Relative safety of first‐time volunteer and replacement donors in West Africa (2009)Moving on from voluntary non‐remunerated donors: who is the best blood donor? (2011)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2005Safety of the Blood Supply in Latin America175 cited
  • 2002International application of the Incidence Rate/Window Period model150 cited
  • 2003Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.126 cited
  • 2003Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001126 cited
  • 2001Screening for viral markers in volunteer and replacement blood donors in West Africa121 cited
  • 1998Risk for Transfusion-Transmitted Infectious Diseases in Central and South America104 cited
  • 2004Window‐period human immunodeficiency virus transmission to two recipients by an adolescent blood donor73 cited
  • 2002Estimated risk of transfusion‐transmitted viral infections in Spain69 cited
  • 2003Transfusion risks of yesterday and of today53 cited
  • 2003Human immunodeficiency virus‐1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing47 cited
  • 2001Reducing the Risk of Blood Transfusion44 cited
  • 2000Transfusion‐transmitted infectious diseases in Argentina, 1995 through 199735 cited

Cited by

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2017Seroprevalence, cost per donation and reduction in blood supply due to positive and indeterminate results for infectious markers in a blood bank in Lima, Peru15 cited
  • 2017Blood donors' attitudes towards voluntary non‐remunerated donation in Trinidad and Tobago11 cited